This study is investigating a biosimilar treatment for rheumatoid arthritis, an autoimmune condition that affects the joints. A biosimilar drug is designed to look similar and behave the same as a currently approved medication. Often these studies arise when the patent of the existing drug comes to an end.
This study has a group starting every week! Call 1800 243 733 to organise a screening appointment.